Stackman RW; Felix Eckenstein; Balz Frei; Doris Kulhanek; Jessica Nowlin; Quinn, JF. Prevention of Age-Related Spatial Memory Deficits in a Transgenic Mouse Model of Alzheimer's Disease by Chronic Ginkgo Biloba Treatment. Under review

Quinn, JF, T. Montine; J Morrow, MD; WR Woodward; D Kulhanek; F Eckenstein. Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer’s disease. Journal of Neuroimmunology 2003 137:32-41

Montine TS, Quinn JF, Milatovec D, Silbert LC, Dang T, Sanchez S, Terry E, Roberts LJ, Kaye JA, Morrow JD. Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer’s disease. Annals of Neurology 2002 Aug; 52(2):175-9

Montine T, Neely M, Quinn JF, Beal M, Markesbery W, Roberts L, Morrow J. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic Biol Med. 2002 Sep 1;33(5):620

Montine KS, TS Montine, JD Morrow, B Frei, D Milatovic, F Eckenstein, Quinn, JF. Mouse cerebral prostaglandins, but not oxidative damage, change with age and are responsive to indomethacin treatment. Brain Research 2002 Mar 15;930(1-2):75-82

Quinn JF, Davis F, Woodward W, Eckenstein F. Beta-amyloid plaques induce neuritic dystrophy in nitric-oxide-containing neurons in a transgenic mouse model of Alzheimer's disease, Experimental Neurology 168:203-212, 2001

Montine TJ, Kaye J, MD, Montine KS, McFarland L, McFarland L, Morrow JD, Quinn JF. Cerebrospinal fluid A-beta 42, tau, and F2-isoprostane concentrations in patients with Alzheimer's disease, other dementias, and in age-matched controls Arch Pathol Lab Med 125: 510-2, 2001